Population-based study on practice variation regarding preoperative systemic chemotherapy in patients with colorectal liver metastases and impact on short-term outcomes

被引:10
作者
Elfrink, Arthur K. E. [1 ,6 ]
Kok, Niels F. M. [7 ]
van der Werf, Leonie R. [6 ,8 ]
Krul, Myrtle F. [7 ]
Marra, Elske [6 ]
Wouters, Michel W. J. M. [6 ]
Verhoef, Cornelis [8 ]
Kuhlmann, Koert F. D. [7 ]
den Dulk, Marcel [2 ]
Swijnenburg, Rutger-Jan [3 ]
te Riele, Wouter W. [9 ]
van den Boezem, Peter B. [10 ]
Leclercq, Wouter K. G. [11 ]
Lips, Daan J. [4 ]
Nieuwenhuijs, Vincent B. [5 ]
Gobardhan, Paul D. [12 ]
Hartgrink, Henk H. [13 ]
Buis, Carlijn, I [1 ]
Grunhagen, Dirk J. [8 ]
Klaase, Joost M. [1 ]
机构
[1] Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
[2] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands
[3] Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[4] Med Spectrum Twente, Dept Surg, Enschede, Netherlands
[5] Isala, Dept Surg, Zwolle, Netherlands
[6] Sci Bur, Dutch Inst Clin Auditing, NL-2333 AA Leiden, Netherlands
[7] Antoni van Leeuwenhoek, Dept Surg, Amsterdam, Netherlands
[8] Erasmus Univ, Erasmus MC Canc Inst, Dept Surg Oncol, Rotterdam, Netherlands
[9] St Antonius Hosp, Dept Surg, Nieuwegein, Netherlands
[10] Radboud Univ Nijmegen, Dept Surg, Med Ctr, Nijmegen, Netherlands
[11] Maxima Med Ctr, Dept Surg, Eindhoven, Netherlands
[12] Amphia Hosp, Dept Surg, Breda, Netherlands
[13] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands
来源
EJSO | 2020年 / 46卷 / 09期
关键词
Colorectal liver metastases; Preoperative chemotherapy; Surgery; Postoperative outcomes; Hospital variation; PERIOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; CANCER; SURGERY; HEPATECTOMY; HEPATOTOXICITY; RESECTABILITY; CETUXIMAB; RESECTION; THERAPY;
D O I
10.1016/j.ejso.2020.03.221
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Definitions regarding resectability and hence indications for preoperative chemotherapy vary. Use of preoperative chemotherapy may influence postoperative outcomes. This study aimed to assess the variation in use of preoperative chemotherapy for CRLM and related postoperative outcomes in the Netherlands. Materials and methods: All patients who underwent liver resection for CRLM in the Netherlands between 2014 and 2018 were included from a national database. Case-mix factors contributing to the use of preoperative chemotherapy, hospital variation and postoperative outcomes were assessed using multivariable logistic regression. Postoperative outcomes were postoperative complicated course (PCC), 30day morbidity and 30-day mortality. Results: In total, 4469 patients were included of whom 1314 patients received preoperative chemotherapy and 3155 patients did not. Patients receiving chemotherapy were significantly younger (mean age (+SD) 66.3 (10.4) versus 63.2 (10.2) p < 0.001) and had less comorbidity (Charlson scores 2+ (24% versus 29%, p = 0.010). Unadjusted hospital variation concerning administration of preoperative chemotherapy ranged between 2% and 55%. After adjusting for case-mix factors, three hospitals administered significantly more preoperative chemotherapy than expected and six administered significantly less preoperative chemotherapy than expected. PCC was 12.1%, 30-day morbidity was 8.8% and 30-day mortality was 1.5%. No association between preoperative chemotherapy and PCC (OR 1.24, 0.98-1.55, p = 0.065), 30-day morbidity (OR 1.05, 0.81-1.39, p = 0.703) or with 30-day mortality (OR 1.22, 0.75-2.09, p = 0.467) was found. Conclusion: Significant hospital variation in the use of preoperative chemotherapy for CRLM was present in the Netherlands. No association between postoperative outcomes and use of preoperative chemotherapy was found. (C) 2020 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:1742 / 1755
页数:14
相关论文
共 37 条
  • [1] Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16
  • [2] Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases?
    Adam, Rene
    Bhangui, Prashant
    Poston, Graeme
    Mirza, Darius
    Nuzzo, Gennaro
    Barroso, Eduardo
    Ijzermans, Jan
    Hubert, Catherine
    Ruers, Theo
    Capussotti, Lorenzo
    Ouellet, Jean-Francois
    Laurent, Christophe
    Cugat, Esteban
    Colombo, Pierre Emmanuel
    Milicevic, Miroslav
    [J]. ANNALS OF SURGERY, 2010, 252 (05) : 774 - 785
  • [3] Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway
    Angelsen, J-H.
    Horn, A.
    Sorbye, H.
    Eide, G. E.
    Loes, I. M.
    Viste, A.
    [J]. BRITISH JOURNAL OF SURGERY, 2017, 104 (05) : 580 - 589
  • [4] [Anonymous], 2014, DUTCH GUIDELINE DATA
  • [5] The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator
    Ayez, N.
    van der Stok, E. P.
    Grunhagen, D. J.
    Rothbarth, J.
    van Meerten, E.
    Eggermont, A. M.
    Verhoef, C.
    [J]. EJSO, 2015, 41 (07): : 859 - 867
  • [6] Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival
    Beppu, Toru
    Miyamoto, Yuji
    Sakamoto, Yasuo
    Imai, Katsunori
    Nitta, Hidetoshi
    Hayashi, Hiromitsu
    Chikamoto, Akira
    Watanabe, Masayuki
    Ishiko, Takatoshi
    Baba, Hideo
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 405 - 413
  • [7] CBS, 2019, GEOGR POP OV NETH
  • [8] CLAVIEN PA, 1992, SURGERY, V111, P518
  • [9] Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients
    de Ridder, Jannemarie
    de Wilt, Johannes H. W.
    Simmer, Femke
    Overbeek, Lucy
    Lemmens, Valery
    Nagtegaal, Iris
    [J]. ONCOTARGET, 2016, 7 (34) : 55368 - 55376
  • [10] Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection
    Duwe, G.
    Knitter, S.
    Pesthy, S.
    Beierle, A. S.
    Bahra, M.
    Schmelzle, M.
    Schmuck, R. B.
    Lohneis, P.
    Raschzok, N.
    Ollinger, R.
    Sinn, M.
    Struecker, B.
    Sauer, I. M.
    Pratschke, J.
    Andreou, A.
    [J]. EJSO, 2017, 43 (09): : 1668 - 1681